DNMT3A and acute myeloid leukemia: In addition, we further analyzed the factors affecting prognosis in patients who did not undergo HSCT and those who received intensive induction therapy, and multifactorial Cox regression analysis still suggested that DNMT3A-mutated/CD7+ was an independent risk factor for AML patients (Supplementary Table 5).